Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NarcX Awarded New Patent for Immediate On-site Medication Disposal, Broadening the Company's Large-Scale Efforts to Reduce the Use of Unused Medications


News provided by

NarcX

Sep 23, 2022, 13:25 ET

Share this article

Share toX

Share this article

Share toX

Vimeo
Vimeo

NarcX, a Utah-based company that eliminates the diversion of medications and frequently abused controlled substances, has been awarded US Patent No. 11,446,531 by the USPTO for its medication disposal solution. The company's patented technology is an environmentally safe, liquid-based solution that immediately renders prescription drugs non-divertible and ultimately non-retrievable in two hours or less. NarcX meets the Drug Enforcement Administration's (DEA) strict definition of non-retrievable. This expedient process eliminates the need for incineration; therefore, eliminating the possibility for diversion. The announcement comes as the nation grapples with an opioid epidemic that shows no signs of slowing down.

VINEYARD, Utah, Sept. 23, 2022 /PRNewswire-PRWeb/ -- NarcX, a Utah-based company that eliminates the diversion of medications and frequently abused controlled substances, has been awarded US Patent No. 11,446,531 by the USPTO for its medication disposal solution. The company's patented technology is an environmentally safe, liquid-based solution that immediately renders prescription drugs non-divertible and ultimately non-retrievable in two hours or less. NarcX meets the Drug Enforcement Administration's (DEA) strict definition of non-retrievable. This expedient process eliminates the need for incineration; therefore, eliminating the possibility for diversion. The announcement comes as the nation grapples with an opioid epidemic that shows no signs of slowing down.

"As many are aware, we've had a major opioid problem in the U.S.," says NarcX Co-Founder and Principal Gavin Collier, "this revolutionary drug disposal solution helps hospitals, pharmacies, law enforcement agencies, and people at home dispose of their unused medication or potentially harmful narcotics safely. This patent will continue our large-scale efforts to combat an epidemic that has already affected too many lives."

"This revolutionary drug disposal solution helps hospitals, pharmacies, law enforcement agencies, and people at home dispose of their unused medication or potentially harmful narcotics safely," says NarcX Co-Founder and Principal Gavin Collier.

Post this

Where it All Began

When the patented technology was originally hypothesized, Collier, along with fellow inventor, entrepreneur and Co-Founder Jordan Erskine, discovered that pharmacies, hospitals, and medical providers had difficulties adopting proper drug disposal methods, primarily due to high costs and complex procedures. In response, NarcX was created and is the first and only independently validated method of on-site destruction for prescription drugs in the United States.

Teaming up with fellow inventors, CEO David Schiller and Co-Founder Christian Kasteler, their revolutionary solution quickly found its way into hospitals, pharmacies, and drug enforcement facilities as a compliant, practical, and cost-effective way to prevent the diversion of unused medications.

From DEA to Families at Home

While this is the only patent held exclusively by NarcX, it will be a game changer in the fight against drug diversion and abuse. The patented technology is already used by law enforcement agencies and healthcare facilities across the country. With this newly-awarded patent, the solution will now be available to people at home who need a safe method to dispose of their unwanted and unused prescription medications.

Convenient and Low-Cost Solutions

"Most conventional drug disposal methods such as collection bins require stockpiling, incineration, are highly susceptible to diversion, and are much more costly" said Co-Founder David Schiller who is now CEO of NarcX, "now, we can offer everyday Americans a convenient and simple disposal method for their unused medications."

Schiller's many years on the frontlines of the opioid epidemic helped shape the primary purpose and structure of the company. "When I was with the DEA, I saw firsthand the devastation that unused and diverted prescription medications can cause. Since 1999, roughly 1 million drug overdose deaths have occurred in the U.S."

Schiller reflected on a grim scenario that has only worsened in the past few months. "According to the Centers for Disease Control, over 107,000 Americans have died from a drug overdose in just the past 12 months. With cases rising so dramatically, I am proud to represent a company that could make a real difference in bringing those numbers down."

NarcX is now partnering with select pharmacies and government agencies to bring its convenient and low-cost solutions directly to families across the country.

For questions, comments, and more, please contact David Schiller at [email protected]

If you have unwanted or unused medications, please visit our website at http://www.narcx.com to find out more.

Thank you for helping us keep our communities safe!

– NarcX Team

Related Links:
U.S. Patent and Trademark Office

NarcX Press Release 02.21.2018

NarcX

Centers for Disease Control and Prevention

NPR: More than a million Americans have died from overdoses during the opioid epidemic
AMA: Nation's drug-related overdose and death epidemic continues to worsen

Media Contact

David Schiller, NarcX, 1 303-434-1630, [email protected]

SOURCE NarcX

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.